Core Viewpoint - The company announced the termination of its plan to acquire 55% of Shanghai Canxi Engineering Equipment Co., Ltd. through a combination of share issuance and cash payment [1] Group 1 - The company had initially planned to issue shares and pay cash to acquire a majority stake in Shanghai Canxi Engineering Equipment Co., Ltd. [1] - The company will issue shares to raise matching funds, which is now no longer proceeding [1] - The company's stock will resume trading on October 13, 2025, following the announcement of the termination [1]

Core Points - The company has decided to terminate the plan to acquire 55% of Shanghai Canxi Engineering Equipment Co., Ltd. through the issuance of shares and cash payment [1] - The stock of the company will resume trading on October 13, 2025 [1] - The transaction was still in the planning stage and no formal substantive agreement had been signed, indicating that the termination will not adversely affect the company's business operations, activities, or financial condition [1]

柏诚系统科技股份有限公司 关于使用闲置募集资金进行现金管理到期赎回的公告 证券代码：601133 证券简称：柏诚股份 公告编号：2025-068 单位：万元 | 受托 方名 称 | 产品名称 | 产品 类型 | 金额 | 起息日 | 到期日 | 年化收 益率 | 收回本金 | 实际收 益 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 江苏 银行 无锡 | 对公人民币结 构性存款 2025 | 保本 浮动 | | | | | | | | | 年第 29 期 99 | 收益 | 3,000.00 | 2025/7 /2 | 2025/1 0/9 | 2.180 % | 3,000.00 | 17.985 | | 振华 支行 | 天 款 0 | 型 | | | | | | | | | 合计 | | 3,000.00 | | | | 3,000.00 | 17.985 | 二、截至本公告日，公司使用暂时闲置募集资金现金管理总体情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整 ...

Core Viewpoint - The company is focusing on expanding its business in semiconductor, new display, biomedicine, and new energy sectors while actively exploring data center opportunities [1] Group 1: Business Focus - The company is concentrating on the semiconductor and semiconductor-related industries [1] - Key clients in the semiconductor sector include major players such as Samsung, SK Hynix, SMIC, Hua Hong Semiconductor, Changxin Memory, Yangtze Memory, and Tongfu Microelectronics [1]

Group 1: Major Asset Restructuring - Guolin Technology is planning a significant asset restructuring by acquiring 91.07% of Xinjiang Kailianjie Petrochemical Co., Ltd. for cash, which will give the company control over Kailianjie, making it a subsidiary [1][2] Group 2: Equity Purchases and Stock Suspension - Diaowei is planning to purchase equity in Rongpai Semiconductor through a combination of issuing shares and cash payments, leading to a stock suspension from September 29, 2025, for up to 10 trading days [3] - Bicheng Co. is also planning to acquire 55% of Shanghai Canxi Engineering Equipment Co., Ltd. through issuing shares and cash, with a stock suspension starting September 30, 2025, for up to 5 trading days [7] Group 3: Changes in Control - Shanhe Pharmaceutical Auxiliary announced a change in its controlling shareholder and actual controller to Wu Changhong due to the inheritance following the death of the previous controller, Yin Zhenglong [4] Group 4: Earnings Forecasts - Yinglian Co. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531.13% to 1672.97%, driven by the fast-moving consumer goods metal packaging sector [5] - Dalian Heavy Industry anticipates a net profit of 474 million to 508 million yuan for the same period, reflecting a growth of 19.91% to 28.52% year-on-year, attributed to steady revenue growth [5] Group 5: Fundraising and Projects - Zhongcai Technology plans to raise up to 4.481 billion yuan through a private placement to fund projects related to low dielectric fiber cloth production and to repay government funds [8] - Luoxin Pharmaceutical is also looking to raise up to 842.4 million yuan for innovative drug research and development and facility upgrades [8] Group 6: Regulatory Actions - *ST Xingnong has been investigated by the China Securities Regulatory Commission for suspected information disclosure violations [9] - Other companies, including Youkeshi and Woton Technology, are also involved in various regulatory and investment activities, including share buybacks and strategic partnerships [10][14]

Group 1 - The core point of the article is that Baicheng Co., Ltd. plans to acquire 55% of Shanghai Canxi Engineering Equipment Co., Ltd. through a combination of issuing shares and cash payment, while also raising matching funds through share issuance [2] - The transaction is expected to be based on a valuation report from a qualified assessment agency, and it is not anticipated to constitute a major asset restructuring or related party transaction according to relevant regulations [2][3] - Baicheng Co., Ltd. has experienced a decline in net profit since its listing in 2023, with projections indicating continued decreases in 2024 and the first half of 2025 [3][4] Group 2 - As of September 29, 2025, Baicheng Co., Ltd. reported total revenue of 2.424 billion yuan, a gross profit of 245.8 million yuan, and a net profit attributable to shareholders of 83.5 million yuan [4] - The company's revenue showed a year-on-year decline of 3.14%, while the net profit experienced a significant drop of 16.10% compared to the previous period [4] - Baicheng Co., Ltd. has a market capitalization of 7.065 billion yuan as of the latest trading session [5]

柏诚股份正在筹划以发行股份及支付现金的方式购买上海灿实工程设备有限公司(以下简称"标的公 司"或"灿实")55%股份，同时公司拟发行股份募集配套资金(以下简称"本次交易")。 因本次交易尚处于筹划阶段，有关事项尚存不确定性，为保证公平信息披露，维护投资者利益，避免造 成公司股价异常波动，根据上海证券交易所的相关规定，经公司申请，公司股票(证券简称：柏诚股 份，证券代码：601133)自2025年9月30日(星期二)开市起开始停牌，预计停牌时间不超过5个交易日。 中国经济网北京9月29日讯柏诚股份（601133）(601133.SH)今晚发布关于筹划发行股份及支付现金购买 资产并募集配套资金事项的停牌公告。 经初步测算，本次交易预计不构成《上市公司重大资产重组管理办法》规定的重大资产重组；根据《上 海证券交易所股票上市规则》等相关法规，本次交易预计不构成关联交易。本次交易不会导致公司实际 控制人发生变更，不构成重组上市。 ...

Core Viewpoint - Bocheung Co., Ltd. plans to acquire 55% of Shanghai Canxi Engineering Equipment Co., Ltd. through a combination of issuing shares and cash payment, while also raising matching funds through share issuance [2]. Group 1: Acquisition Details - The acquisition involves signing an investment cooperation framework agreement with several parties, including Zhou Huajie, Tai Qing, Bai Lingyun, and Canxi Technology Development (Shanghai) Partnership [2]. - The pricing of the transaction will be based on a report from a qualified assessment agency and will be determined through negotiation among the parties involved [2]. - The transaction is not expected to constitute a major asset restructuring as defined by relevant regulations, nor will it lead to a change in the actual controller of the company [2]. Group 2: Company Background - Bocheung Co., Ltd. was founded in 1994 and specializes in providing integrated cleanroom system solutions for high-tech industries, covering sectors such as semiconductors, new displays, life sciences, and health [3]. - The company is one of the few domestic providers capable of undertaking mainstream projects across multiple industries [3]. - Bocheung Co., Ltd. was listed on the Shanghai Stock Exchange on April 10, 2023, but its performance post-listing has been underwhelming, with net profits declining in 2023 and continuing to decrease in 2024 and the first half of 2025 [3]. Group 3: Financial Performance - As of June 30, 2025, Bocheung Co., Ltd. reported total revenue of 2.424 billion yuan, a gross profit of 245.8 million yuan, and a net profit attributable to shareholders of 83.5 million yuan [4]. - Year-on-year revenue growth was -3.14%, with a gross profit margin decline of -16.10% [4]. - The company's market capitalization was 7.065 billion yuan as of September 29, 2025 [4].

新京报贝壳财经讯9月29日，柏诚股份（601133）公告称，公司拟筹划以发行股份及支付现金的方式购 买上海灿实工程设备有限公司55%股份，同时拟发行股份募集配套资金。本次交易预计不构成重大资产 重组，也不构成关联交易。为保证公平信息披露，维护投资者利益，公司股票自2025年9月30日起停 牌，预计停牌时间不超过5个交易日。 ...

Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]